(Q57605693)

10

0 references

Jean Dallongeville

3

object named as

Jean Dallongeville

0 references

Luc Defebvre

12

object named as

Luc Defebvre

0 references

author name string

Caroline Moreau

1

0 references

Véronique Brunaud-Danel

2

0 references

Alain Duhamel

4

0 references

Laurence Laurier-Grymonprez

5

0 references

Jacques de Reuck

6

0 references

Anne Charlotte Wiart

7

0 references

Thierry Perez

8

0 references

Florence Richard

9

0 references

Régis Bordet

11

0 references

Alain Destée

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

13

0 references

publication date

14 September 2011

0 references

published in

0 references

volume

13

0 references

issue

2

0 references

page(s)

194-201

0 references

cites work

Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

VEGF promoter haplotype and amyotrophic lateral sclerosis (ALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Low levels of the vascular endothelial growth factor in CSF from early ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Deregulation of the hypoxia inducible factor-1α pathway in monocytes from sporadic amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Expression of angiogenic factors in rabbit spinal cord after transient ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

[Epidemiology of amyotrophic lateral sclerosis].

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Prevalence and therapeutic control of hypertension in 30,000 subjects in the workplace.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

A bootstrap resampling procedure for model building: Application to the cox regression model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Complications and consequences of obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Onset, natural history and outcome in idiopathic adult motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Early symptom progression rate is related to ALS outcome: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Prognosis in amyotrophic lateral sclerosis: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Natural history of amyotrophic lateral sclerosis in a database population Validation of a scoring system and a model for survival prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110

Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2011.610110